Presentation is loading. Please wait.

Presentation is loading. Please wait.

Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Similar presentations


Presentation on theme: "Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)"— Presentation transcript:

1 Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
Brianna N. Smith, Michael Savona, Rami S. Komrokji  Clinical Lymphoma, Myeloma and Leukemia  Volume 19, Issue 1, Pages 1-8 (January 2019) DOI: /j.clml Copyright © 2018 Elsevier Inc. Terms and Conditions

2 Figure 1 How do I Treat CMML?
Abbreviations: AHSCT = autologous hematopoietic stem cell transplant; CMML = chronic myelomonocytic leukemia; HMA = hypomethylating agent; NGS = next generation sequencing; WHO = World Health Organization. Clinical Lymphoma, Myeloma and Leukemia  , 1-8DOI: ( /j.clml ) Copyright © 2018 Elsevier Inc. Terms and Conditions


Download ppt "Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)"

Similar presentations


Ads by Google